Patents Issued in March 16, 2017
  • Publication number: 20170071821
    Abstract: A method and a control panel are described for facilitating the control of a bathing unit system so that the bathing unit system is caused to transition between operating in accordance with a first operational mode to operating in accordance with a second operational mode. A control signal is generated in response to a unitary user input event performed by a user at a control panel of the bathing unit system, the control signal conveying an ambiance activation command associated with a specific ambience setting, the generation of the control signal comprising selecting the specific ambience setting from a set of ambience settings stored in a memory device. The control signal is then transmitted from the control panel to the controller over a communication link where it is processed to cause the bathing unit system to transition from being in the rest mode to operating in accordance with the specific ambience setting.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 16, 2017
    Inventors: Benoit LAFLAMME, Christian BROCHU
  • Publication number: 20170071822
    Abstract: A spa is provided that includes: a basin; a motor having a shaft defining a rotation axis; a hub mounted to the shaft, the hub having North and South pole domains spaced apart from each other and arranged to encircle the rotation axis in alternating relation; and an impeller which is disposed in the basin in axially spaced relation to the hub and is at least substantially constrained against movement but for rotation about the axis, the impeller including a rotor body of a non-magnetic, electrically-conductive material having relatively low magnetic permeability. The improvement in which is that there are lights and coils coupled to the impeller for rotation therewith, the lights and coils being coupled and adapted such that, in use, the rotating magnetic fields associated with the drive hub created induced currents in the coils which actuate the lights and create a net force that rotates the impeller.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: Minh Sang Tran, Chris Alexander
  • Publication number: 20170071823
    Abstract: An electrotherapy system includes a control device, a pulse generator and an electrode pad unit. The control device receives a user input associated with one of twelve meridians of a human, and outputs a control signal associated with the one of the twelve meridians. The pulse generator generates an electrical stimulation signal according to a reference frequency of a reference signal and the one of the twelve meridians with which the control signal is associated. The electrode pad unit contacts a user at a location corresponding to the one of the twelve meridians, and is coupled to the pulse generator for introducing the electrical stimulation signal from the pulse generator to the user.
    Type: Application
    Filed: August 11, 2016
    Publication date: March 16, 2017
    Inventor: Kuang-Cheng CHAO
  • Publication number: 20170071824
    Abstract: An acupressure apparatus includes a tub configured to receive the user's feet for acupressure treatment, an acupressure station having a pair of designated foot placing areas for facilitating accurate positioning of the feet on the acupressure station, a plurality of upward projections formed on an upper surface of the acupressure station, and a plurality of watering holes formed around the projections, and a water supply conduit connected to the bottom wall of the tub for supplying compressed water by operation of a water pump. The watering holes formed in the acupressure station are directed to acupressure points of the feet such that the compressed water delivered through the watering holes provides acupressure stimulations to the acupressure points of the feet.
    Type: Application
    Filed: September 10, 2015
    Publication date: March 16, 2017
    Inventors: Kil Hwan Park, Kyu Sung Park, Kyu Min Park
  • Publication number: 20170071825
    Abstract: Meridian bending needling method requires practitioners to obliquely insert an acupuncture needle by 10-30 degrees, and subsequently move the needle along subcutaneous muscle layer until the needle completely merges into patients' skin. This type of acupuncture method allows practitioners to stimulate multiple acupoints and meridian channel at the same time. The invented filiform merge cluster needle device applied in meridian-bending needling method comprises two or more single needles fixed in parallel; said single needle comprises five parts including a needle tip, needle body, needle root, needle handle, and needle end connected respectively. Single needles are fixed together by binding, tape, welding or snapping. Compared to existing technologies, the therapeutic effects of meridian-bending needling method are remarkable, and the method is much safer.
    Type: Application
    Filed: August 22, 2016
    Publication date: March 16, 2017
    Inventors: Canglin Li, Zuoqiang Li, Li Ma, Liting Zhang, Yanbin Gao
  • Publication number: 20170071826
    Abstract: A septum is penetrable by a needle for decontamination by physical interaction. The septum can include a peripheral portion, an exterior surface], and an interior surface. A penetration portion extends between the exterior and interior surfaces, is spaced inwardly of the peripheral portion, and is penetrable by the needle or other penetrating element. A flex portion is located between the penetration portion and the peripheral portion. A thicker portion extends between the flex portion and the penetration portion, and defines an increased thickness between the exterior and interior surfaces relative to the flex portion. The flex portion is flexible inwardly relative to the peripheral portion during penetration of the penetration portion by a needle or other penetrating element. The penetration portion physically interacts with and decontaminates the needle when it penetrates the septum. The septum may also reduce or prevent retrograde contamination when the needle is withdrawn.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 16, 2017
    Inventor: Daniel Py
  • Publication number: 20170071827
    Abstract: A holder (12) for checking non-compliance of a blister package has a pocket (60) into which the blister package is inserted. The front of the pocket is a transparent plate (128). Rectangular openings of wells (133) in the front face of the box (121) are positioned behind the blisters of the blister package. Each well contains light-sensitive elements (134). Non-compliance occurs when a blister of a used blister package is in an unopened condition. The sensing elements (134) detect this by ambient light in the pocket not reaching the elements. An electrical circuit in the box (121) monitors the elements (134) and provides a signal indicating a non-compliance condition if a blister in the returned package is unopened. Information identifying the unopened blister is stored in the circuit. A variable light source can be provided.
    Type: Application
    Filed: February 26, 2015
    Publication date: March 16, 2017
    Applicant: Manrex Pty, LTD
    Inventor: Gerard Stevens
  • Publication number: 20170071828
    Abstract: A feeding bottle apparatus comprising a cylindrical bottle for containing a flowable material, having a top with an opening, a bottom, a length, at least a first portion of the bottle curving along the length, and markings indicative of an amount of flowable material; a cap attachable to the top of the bottle, having an opening aligned with the opening of the bottle; and a tube extending through the opening of the cap and the opening of the bottle, having a first end extending out of the bottle and a second end disposed within the bottle, the first end having an opening and a deflector member, the second end extending substantially the length of the bottle and having at least one bottom member; wherein the bottle is formed of a flexible material such that pressure applied to the bottle discharges the flowable material through the tube.
    Type: Application
    Filed: September 8, 2016
    Publication date: March 16, 2017
    Inventor: Sandra D. Wilson
  • Publication number: 20170071829
    Abstract: A bottle stand includes a bottle holder and at least one posably flexible leg having a proximal end attached to the bottle holder and a distal end resting on a surface, the leg comprising a first member and a second member telescopically coupled to the first member.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Inventors: David Marshall Plavan, Fanony B. Montoya-Plavan
  • Publication number: 20170071830
    Abstract: A fluid delivery tube bracket is disclosed herein, comprising a central pocket formed by a rear wall, first and second end walls, and first and second side walls, the first end wall having a first slot configured to receive a first medical tube, and the second end wall having a second slot configured to receive a second medical tube. The first side wall includes a first port plug receiving portion configured to receive a first connector plug when in an open position, and the second side wall includes a second port plug receiving portion configured to support a second port plug when in a closed position. Additional product and method embodiments also are disclosed.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: Ryan Nelson Duval, Jill Susan Duval
  • Publication number: 20170071831
    Abstract: A primer composition for a resin cured material according to the present disclosure comprising (A) a polymerizable monomer having a solubility parameter (an SP value) in the range of from 7.0 to 10.0, (B) a volatile organic solvent, (C) a polymerization catalyst and/or a polymerization accelerator, and (D) a polymerizable monomer having at least two polymerizable group.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Applicant: SHOFU INC.
    Inventors: Daisuke HARA, Naoya KITADA
  • Publication number: 20170071832
    Abstract: A cosmetic oil/water emulsion comprising a) 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: Octocrylene), b) 4-(tert.-butyl)-4?-methoxydibenzoyl methane (INCI: Butylmethoxydibenzoyl methane), c) licorice extract or licochalcone A.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Applicant: BEIERSDORF AG
    Inventors: Stephan RUPPERT, Claudia STEIKERT, Alexandra BLOHM
  • Publication number: 20170071833
    Abstract: A composition is provided, wherein the composition comprises a water-swellable, water insoluble polymer, a blend of a hydrophilic polymer and a complementary oligomer capable of hydrogen bonding to the hydrophilic polymer, and a whitening agent, preferably a peroxide. The composition finds utility as a tooth whitening composition and is applied to the teeth in need of whitening, and then removed when the degree of whitening has been achieved. In certain embodiments, the composition is translucent. Methods for preparing and using the compositions are also disclosed.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Inventors: Parminder Singh, Gary W. Cleary, Sri Mudumba, Mikhail M. Feldstein, Danir F. Bayramov
  • Publication number: 20170071834
    Abstract: The invention relates to an anhydrous composition that provides stable oxyresveratrol in a cosmetically or pharmaceutically acceptable medium with butylene glycol. Preferably, the oxyresveratrol is present within the composition in a concentration in the range of between about 0.00001% and about 20%. Preferably, the butylene glycol is present in the composition in a concentration in the range of between about 0.00001% and about 30%. The anhydrous composition may consist solely of oxyresveratrol and butylene glycol.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 16, 2017
    Inventors: Kavitha Murugesan, Elliot Isaacs, Daniel Isaacs
  • Publication number: 20170071835
    Abstract: A cosmetic cleansing agent includes biosurfactants, serving as the surfactants, in combination with an anionic surfactant and a thickener. The cosmetic cleansing agent in total includes less than 0.1 wt. %. polyethylene glycol, polypropylene glycol, ethylene oxide-containing compounds, and propylene oxide-containing compounds. A cosmetic cleansing agent having excellent foaming properties and cleansing properties may thus be provided, even though no, or substantially no, foam-promoting ethylene oxide-containing surfactants are present.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Applicant: Henkel AG & Co. KGaA
    Inventors: Heike Schelges, Maria Tretyakova, Brigitte Ludwig
  • Publication number: 20170071836
    Abstract: A sulfate surfactant-free cosmetic cleansing agent includes biosurfactants in combination with acyl lactylates as the surfactants. The cosmetic cleansing agent has an outstanding washing and foaming behavior.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Applicant: Henkel AG & Co. KGaA
    Inventors: Heike Schelges, Maria Tretyakova
  • Publication number: 20170071837
    Abstract: A cleaning agent, in particular a cosmetic cleaning agent, includes a surfactant content that is largely or only composed of biosurfactants, in combination with a foam dispenser.
    Type: Application
    Filed: September 6, 2016
    Publication date: March 16, 2017
    Applicant: Henkel AG & Co. KGaA
    Inventors: Heike Schelges, Maria Tretyakova
  • Publication number: 20170071838
    Abstract: Methods and kits for treating hair or preventing damage in the relaxing of hair are disclosed herein. Hair that is damaged during a relaxing treatment with hydroxide-containing relaxing agents, can be treated with formulations containing one or more active agents. The active agent formulations can be applied simultaneously with the hair relaxing formulation, or optionally applied immediately following application of the relaxing formulation, to reduce damage and breakage. Use of the active agent formulation along with a relaxing treatment can be used to control the level of curl achieved or retained in the relaxed hair, as compared to the natural amount of curl in the untreated hair.
    Type: Application
    Filed: November 2, 2016
    Publication date: March 16, 2017
    Inventors: Eric D. Pressly, Craig J. Hawker
  • Publication number: 20170071839
    Abstract: Personal care products useful for the maintenance of personal appearance and good health and minor treatments that do not require professional health care, as well as products that provide a combination of anti-microbial, anti-oxidant, anti-inflammatory, and anti-aging properties and are suitable for use without a prescription. The products utilize a biomembrane permeable organosulfur compound that can redox cycle between thiol, disulfide, and thiosulfinate forms in response to oxidants and antioxidants inside and outside of cells. Example products include an anti-microbial toothpaste with anti-plaque properties, an anti-inflammatory skin lotion with antioxidant, antimicrobial, and deodorant properties, and an anti-toxin skin lotion with anti-arsenicosis properties.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 16, 2017
    Inventor: David Michael Ott
  • Publication number: 20170071840
    Abstract: Microemulsions and soluble alkali metal salts of relatively insoluble aglycone polyphenols within oral hygienic products are disclosed for treating oral inflammatory disorders. The formulations can act as a bactericide or bacteriostat. The methods include the process associated with the formation of a high temperature polyphenol/surfactant concentrate, a nano-particulate precipitation process in the presence of a surfactant and the solubilization of relatively insoluble aglycone polyphenols/flavonoids by the formation of soluble alkali metal salts within alkaline oral compositions. Also disclosed are compositions that persist in the oral cavity, penetrate teeth, and facilitate or enhance the delivery of chemical elements and active ingredients to teeth for preventing or treating disorders and diseases of the oral cavity. Methods of use, and methods of making, the aforementioned compositions are also disclosed.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventors: Philip J. BIRBARA, Jeffrey S. CUMMINGS, Karl GINTER, Krishna RAMAN
  • Publication number: 20170071841
    Abstract: The present invention relates to a method for preparing 3,6-anhydro-L-galactose, and use thereof. More specifically, 3,6-anhydro-L-galactose, which is a monosaccharide constituting agar, is produced in a high yield through chemical and enzymatic methods, and the physiological activities thereof such as whitening, moisturizing, antioxidant, anti-inflammatory activities and the like are displayed, thereby enabling industrial use thereof.
    Type: Application
    Filed: November 15, 2016
    Publication date: March 16, 2017
    Applicant: Korea University Research and Business Foundation
    Inventors: Kyoung Heon Kim, In Geol Choi, Nam Joo Kang, Eun Ju Yun, Sae Young Lee, Ji Hye Kim, Young Ah Kim, Bo Bae Kim, Eun Ji Baek
  • Publication number: 20170071842
    Abstract: Cosmetic cleansing agents include biosurfactants and have prebiotic activity. The prebiotic effect is produced by combining biosurfactants with anionic surfactants. The cosmetic cleansing agent according to the invention also has excellent foaming properties and washing properties. The present invention also relates to the use of biosurfactants as a prebiotically effective component of cosmetic cleansing agents.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Applicant: Henkel AG & Co. KGaA
    Inventors: Heike Schelges, Maria Tretyakova, Brigitte Ludwig
  • Publication number: 20170071843
    Abstract: A hair treatment agent in which penetrability of a modified peptide into the internal structure of the hair can be enhanced even under the conditions of acidic pH, and a method for causing a modified peptide to penetrate into the hair, are provided. Disclosed is a hair treatment agent at a pH of from 3.5 to 5.
    Type: Application
    Filed: August 26, 2016
    Publication date: March 16, 2017
    Inventors: Yohei MATSUMOTO, Atsushi YAMADA, Naoto MATSUMOTO
  • Publication number: 20170071844
    Abstract: The invention is directed to the use of at least one peptide of formula: X-(Xaa1)n-Pro*-(Xaa2)m-Y (I) With: —n=0, 1 or 2; -m=0 or 1 and if m=0 then n?0-Xaa1 is: -An hydrophobic aminoacid selected from Alanine (Ala, A), Valine (Val, V), Methionine (Met, M), Leucine (Leu, L), Isoleucine (Ile, I), Phenylalanine (Phe, F), Proline (Pro, P) and analogues and derivatives thereof; —A polar aminoacid selected from Serine (Ser, S), Threonine (Thr, T), Tyrosine (Tyr, Y), Asparagine (Asn, N), Glutamine (Gln, Q) and analogues and derivatives thereof; —or Glycine (Gly, G); When n=2 the two aminoacids Xaa1 can be the same or different; -Xaa2 is: —An hydrophobic aminoacid selected from Alanine (Ala, A), Valine (Val, V), Methionine (Met, M), Leucine (Leu, L), Isoleucine (Ile, I), Phenylalanine (Phe, F), Proline (Pro, P) and analogues and derivatives thereof; —A basic aminoacid selected from Arginine (Arg, R), Lysine (Lys, K) and Histidine (His, H) and analogues and derivatives thereof; —Glycine (Gly, G) or Serine (Ser, S); —A
    Type: Application
    Filed: November 28, 2016
    Publication date: March 16, 2017
    Applicant: Sederma
    Inventors: Olivier Peschard, Philippe Mondon
  • Publication number: 20170071845
    Abstract: Compositions of the invention comprise 8-oxoguanine glycosylase (OGG1) and SIRT6 activating peptide G-A-G-V-S-A-E-NH2. Compositions of the invention exhibit anti-aging effects by promoting the repair of skin cell DNA and/or by protecting skin cell DNA from UV damage.
    Type: Application
    Filed: November 30, 2016
    Publication date: March 16, 2017
    Inventors: Nadine Pernodet, Kelly Dong, Edward Pelle
  • Publication number: 20170071846
    Abstract: Exfoliants, i.e. cosmetic cleansers, include an abrasive component. The exfoliants according to the invention include biosurfactants as surfactants and also include a natural thickening agent. The abrasive component, the biosurfactants, and the thickening agent of the exfoliants according to the invention are based on natural, renewable and biologically degradable raw substances.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 16, 2017
    Applicant: Henkel AG & Co. KGaA
    Inventors: Heike Schelges, Maria Tretyakova
  • Publication number: 20170071847
    Abstract: The present disclosure relates to cosmetic compositions comprising an organosilane (A) having the formula: (R1)n(R2O)(3-n)SiR3O(CH2CH2O)a(C3H6O)bR4 where n is 1, 2, or 3, a?1, b may vary from 0 to 30, with the proviso a?b, R1 is a hydrocarbon group containing 1 to 12 carbon atoms, R2 is hydrogen or an alkyl group containing 1 to 6 carbon atoms, R3 is a divalent hydrocarbon group containing 2 to 12 carbon atoms, R4 is hydrogen, R1, or an acetyl group; and a cosmetic ingredient (B), and optionally in a cosmetically acceptable medium.
    Type: Application
    Filed: November 4, 2016
    Publication date: March 16, 2017
    Applicant: Dow Corning Corporation
    Inventors: MICHAEL SALVATORE FERRITTO, LENIN JAMES PETROFF
  • Publication number: 20170071848
    Abstract: This document provides skin care compositions that can include one or more saponin extracts. In some cases, the skin care compositions provided herein can include a saponin extract (e.g., a Sapindus mukorossi extract). In some cases, the skin care compositions provided herein can include a Sapindus mukorossi extract, allantoin, carnosine, and a plant extract blend. The plant extract blend can include bioflavonoids (e.g., citrus bioflavonoids), a Brassica oleracea ver. italica (i.e., broccoli) extract, and an Aloe barbadensis leaf extract, or combinations thereof.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventor: Dzung Le
  • Publication number: 20170071849
    Abstract: A cosmetic skin care product comprising a therapeutically effective amount of a honey extract is described, the honey extract having a phenolic compound to saccharides ratio of at least 5 times greater than the raw honey from which the extract is derived and including a mixture of at least ethanol, water and one or more MMP inhibitory phenolic compounds.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 16, 2017
    Inventors: Gregor Aaron Steinhorn, Sigrid Vorwerk
  • Publication number: 20170071850
    Abstract: Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.
    Type: Application
    Filed: April 21, 2016
    Publication date: March 16, 2017
    Inventors: Reinhard Vehring, Michael Steven Hartman, Adrian Edward Smith, Vidya B. Joshi, Sarvajna Kumar Dwivedi
  • Publication number: 20170071851
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 16, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Publication number: 20170071852
    Abstract: The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: Kazutaka KIDO, Takashi NAGANO
  • Publication number: 20170071853
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Application
    Filed: November 28, 2016
    Publication date: March 16, 2017
    Inventors: Michael R. Robinson, James A. Burke, Rhett M Schiffman, Alazar N. Ghebremeskel
  • Publication number: 20170071854
    Abstract: The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: Ingvild Haug, Kurt Ingar Draget
  • Publication number: 20170071855
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: July 8, 2016
    Publication date: March 16, 2017
    Inventors: Stephen PERRETT, Fredric Jay COHEN, Gopi VENKATESH
  • Publication number: 20170071856
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 16, 2017
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20170071857
    Abstract: Described herein are methods of delivering a nanoparticle across the blood brain barrier to the brain of a subject by administering to the subject a nanoparticle having a nanoparticle core and a targeting agent. A variety of targeting agents may serve to promote delivery of the described nanoparticle.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Inventors: DEVIN WILEY, ANDREW CLARK, MARK E. DAVIS
  • Publication number: 20170071858
    Abstract: The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: Keelung Hong, Daryl C. Drummond, Dmitri Kirpotin
  • Publication number: 20170071859
    Abstract: Multi-phase release compositions, methods of using the compositions, and methods for manufacturing the compositions are provided. Multi-phase release compositions include ingredients useful in sports nutrition including ingredients useful in muscle building, energy output and weight loss. Sports nutrition ingredients are designed for immediate and extended release dependent on the particular sport nutrition motivated use. One sports nutrition ingredient that can be utilized in either or both the immediate release phase or the extended release phase is phosphatidic acid.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventor: Tyler O. White
  • Publication number: 20170071860
    Abstract: Embodiments may also include a system for reducing a solvent concentration in a plurality of microparticles. The system may include a solvent extraction tank. In the solvent extraction tank, a mixture including the plurality of microparticles and the solvent may be contacted with water to form an aqueous suspension. A first portion of the solvent may dissolve into the water of the aqueous suspension to reduce the solvent concentration in the plurality of microparticles. The system may also include a concentration unit in fluid communication with the solvent extraction tank. The concentration unit may further reduce the solvent concentration in the plurality of microparticles. A microparticle concentrate may be formed. The system may further include a washing unit. In the washing unit, the microparticle concentrate may be contacted with a washing solution and may form an amalgam of washed particles.
    Type: Application
    Filed: November 21, 2016
    Publication date: March 16, 2017
    Applicant: AntriaBio, Inc.
    Inventor: Greg Bryden Sebring
  • Publication number: 20170071861
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 12, 2016
    Publication date: March 16, 2017
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Everardus ORLEMANS, John R. PLACHETKA, Mark SOSTEK
  • Publication number: 20170071862
    Abstract: The invention relates to a pharmaceutical dosage form which is particularly useful for the prevention of an overdose of the pharmacologically active ingredient contained therein after accidental or intentional simultaneous administration of a plurality of the dosage forms containing an overall supratherapeutic dose of the pharmacologically active ingredient.
    Type: Application
    Filed: September 9, 2016
    Publication date: March 16, 2017
    Applicant: GRÜNENTHAL GMBH
    Inventors: KLAUS WENING, Sebastian Schwier, Ulrike Bertram
  • Publication number: 20170071863
    Abstract: The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.
    Type: Application
    Filed: September 9, 2016
    Publication date: March 16, 2017
    Applicant: Sun Pharmaceutical Industries Ltd.
    Inventors: Rajamannar Thennati, Shirish Kulkarni, Amol Kulkarni, Vimal Kaneria, Mukesh Sharma
  • Publication number: 20170071864
    Abstract: Therapeutic compositions deliver a therapeutic amount of methylphenidate in a delayed and extended release formulation. The dosage form exhibits a lag time prior to release of from 6 to 8 hours or longer, followed by a sustained release period.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Inventors: David Lickrish, Feng Zhang
  • Publication number: 20170071865
    Abstract: Multi-layer microcapsules comprising a core comprising one or more active agents and two or more shells comprised of a wall-forming polymeric material, an opaque substance and a fatty acid salt, which are rupturable upon rubbing or pressing on the skin, are disclosed. The microcapsules are characterized by improved lightness values (L*) and/or compatibility in aqueous solution-containing formulations. Cosmetic or cosmeceutic formulations comprising the microcapsules, which can be, for example, body skin care formulation or facial skin care formulations, are also provided.
    Type: Application
    Filed: March 4, 2015
    Publication date: March 16, 2017
    Inventors: Danny GOLDSTEIN, Olga PRIVALOVA, Lior BEN-ALTABET, Yaniv MENACHEM, Hanan HAJ, Shaher DUCHI
  • Publication number: 20170071866
    Abstract: The present disclosure concerns nanoparticles loaded with active ingredients with controlled average diameter, their processes of preparation, their formulations, and their therapeutic uses.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventor: Christelle Zandanel
  • Publication number: 20170071867
    Abstract: The present invention provides, among other things, nanoparticle compositions including a plurality of nanoparticles, each of which is comprised of a biodegradable or biocompatible polymer arranged in a nanoparticle structure defining an internal lumen and an external surface and one or more of a preparation of hydrophilic cellular components and a preparation of hydrophobic cellular components. In some embodiments, the preparation of hydrophilic cellular components is encapsulated within the internal lumen and the preparation of hydrophobic cellular components is associated with the external surface. Various methods of making and using disclosed nanoparticle compositions are also provided.
    Type: Application
    Filed: November 28, 2016
    Publication date: March 16, 2017
    Inventors: Howard Sosin, Michael Caplan, Tarek Fahmy
  • Publication number: 20170071868
    Abstract: A PoP nano-composite structure includes a first nano-particle containing a drug therein, and second nano-particles that surround a surface of the first nano-particle and are coated by a protein alpha-synuclein. Combination of the nano-particles and release of the drug can be controlled by the protein alpha-synuclein.
    Type: Application
    Filed: September 22, 2014
    Publication date: March 16, 2017
    Inventors: Seung-Ryeoul Paik, Daekyun Lee
  • Publication number: 20170071869
    Abstract: The subject invention provides an oral patch comprising: a) a liner; and b) a film composition thereon, the film composition comprising (i) laquinimod in an amount of about 0.1%-20% by weight of the film composition, and (ii) one or more film forming agents in a total amount of about 40%-90% by weight of the film composition. The subject invention also provides a method for delivering laquinimod across the oral mucosa of a subject, or for treating a human subject afflicted with a form of multiple sclerosis, comprising periodically administering to the human subject an oral patch as described herein. The subject invention also provides an oral patch as described herein for use in treating a human subject afflicted with a form of multiple sclerosis.
    Type: Application
    Filed: March 13, 2015
    Publication date: March 16, 2017
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ralph Stefan, Hans Juergen Mika, Claudia Lauer, Dirk Schenk, Sabine Prohl
  • Publication number: 20170071870
    Abstract: Transdermal delivery devices for the delivery of cannabidiol (CBD) and related moieties are shown and described. In a reservoir-patch design, a microporous, hydrophilic membrane and a backing define a reservoir that houses a mixture of CBD, a polar liquid, and a gelling agent, along with other moieties that seem to be enhanced or bioavailabilty of increased by the same. The hydrophilic membrane is coated with an amine-compatible silicone skin adhesive. In a monolithic design, a release liner is coated with a mixture of CBD and a PIB or amine-compatible silicone skin adhesive laminated to the backing material. In using CBD as a pure compound or as one to combine with other moieties, the invention is able to control delivery better than the prior art. Construction of the Transdermal patch of reservoir type is also taught, which enables things such as Vitamin B 12 to become part of the complex deliverable by the inventions.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventor: Ludwig Weimann